The company began rolling out the first phase of its pilot program earlier this year with sites including both healthcare provider and manufacturer organizations. The first phase of IDSC pilot results confirmed:
1. Solving problems in purchasing, tracking and using implantable devices requires collaboration among providers and suppliers, as they must work together to address and improve shared processes.
2. Even basic automation begins to identify process gaps and breakdowns, leading to opportunities for process improvements and greater savings than from just the automation itself.
3. Clean, accurate and up-to-date item information and the ability to manage accurate pricing are essential to a successful IDSC.
GHX estimates the cardiac and orthopedic implantable device market is a more than $40 billion market with no current solution addressing the entire healthcare value chain from device supplier to hospital or surgical center to patient.
More Articles on Orthopedic Devices:
MiMedx Group Raises Nearly $5B Through Callable Warrants
